Vineeta founded the company in 2021 after 15 years in drug development in major pharmaceutical companies and is a co-inventor on 13 granted patents and 4 filed patents. Biotech start-ups like Vitarka Therapeutics need funds for research and development from the get go and Discovery Park Ventures invested £150,000 as part of a seed round. More recently, Vineeta raised over 500,000 dollars of investment through the IndieBio New York Program as the only UK firm in the cohort.